ReviewHuman vaccines & immunotherapeutics2016

Nivolumab, anti-programmed death-1 (PD-1) monoclonal antibody immunotherapy: Role in advanced cancers.

Arun Rajan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.